Analyst Recommendations

Outperform Recommendation Issued On KOF By Bradesco
Bradesco analyst issues OUTPERFORM recommendation for KOF on February 11, 2026 09:46AM ET. KOF was trading at $112.45 at issue of the analyst recommendation.The overall analyst consensus :...

February 11, 2026   KOF 1.71%

Buy Recommendation Issued On KC By Goldman Sachs
Goldman Sachs analyst issues BUY recommendation for KC on February 10, 2026 09:22PM ET. The previous analyst recommendation was Neutral.KC was trading at $13.12 at issue of the...

February 10, 2026   KC -1.38%

Neutral Recommendation Issued On BHP By Citigroup
Citigroup analyst issues NEUTRAL recommendation for BHP on February 10, 2026 06:23PM ET. The previous analyst recommendation was Neutral.BHP was trading at $72.34 at issue of the analyst...

February 10, 2026   BHP 3.20%

Overweight Recommendation Issued On OMAB By Barclays
Barclays analyst issues OVERWEIGHT recommendation for OMAB on February 10, 2026 10:45AM ET. The previous analyst recommendation was Overweight.OMAB was trading at $127.6 at issue of the analyst...

February 10, 2026   OMAB 2.59%

Overweight Recommendation Issued On VLRS By Barclays
Barclays analyst issues OVERWEIGHT recommendation for VLRS on February 10, 2026 10:45AM ET. The previous analyst recommendation was Overweight.VLRS was trading at $10.47 at issue of the analyst...

February 10, 2026   VLRS 5.10%

Neutral Recommendation Issued On GSK By Citigroup
Citigroup analyst issues NEUTRAL recommendation for GSK on February 9, 2026 05:48PM ET. The previous analyst recommendation was Neutral.GSK was trading at $58.765 at issue of the analyst...

February 9, 2026   GSK 0.34%

Sector Perform Recommendation Issued On VALE By Scotiabank
Scotiabank analyst issues SECTOR PERFORM recommendation for VALE on February 9, 2026 03:38PM ET. The previous analyst recommendation was Sector Perform.VALE was trading at $16.485 at issue of...

February 9, 2026   VALE 2.28%

Hold Recommendation Issued On GSK By Cowen & Co.
Cowen & Co. analyst issues HOLD recommendation for GSK on February 9, 2026 12:57PM ET. The previous analyst recommendation was Hold.GSK was trading at $60.23 at issue of...

February 9, 2026   GSK 0.34%

Buy Recommendation Issued On TEVA By Goldman Sachs
Goldman Sachs analyst issues BUY recommendation for TEVA on February 9, 2026 12:37PM ET. The previous analyst recommendation was Buy.TEVA was trading at $34.69 at issue of the...

February 9, 2026   TEVA 0.20%

Overweight Recommendation Issued On BUD By Wells Fargo
Wells Fargo analyst issues OVERWEIGHT recommendation for BUD on February 9, 2026 11:26AM ET. The previous analyst recommendation was Overweight.BUD was trading at $75.81 at issue of the...

February 9, 2026   BUD 0.78%